Welcome to our dedicated page for Ingredion SEC filings (Ticker: INGR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ingredion Incorporated (NYSE: INGR) files a range of reports and disclosure documents with the U.S. Securities and Exchange Commission that provide detailed information about its operations as a global ingredient solutions provider. These SEC filings cover the company’s activities in turning grains, fruits, vegetables and other plant-based materials into value-added ingredient solutions for food, beverage, animal nutrition, brewing and industrial markets, and its role as a manufacturer serving customers in more than 120 countries.
Through its periodic reports, such as annual and quarterly filings, Ingredion presents condensed consolidated financial results, segment information and commentary on business drivers. The company’s disclosures reference business groupings like Texture & Healthful Solutions, Food & Industrial Ingredients—U.S./Canada, Food & Industrial Ingredients—LATAM and an All Other category, along with discussions of net sales, operating income and regional performance. These filings also describe factors affecting results, including raw material costs, volume trends and regional demand conditions.
Current reports on Form 8-K provide timely information on material events. Recent 8-K filings have described the approval of new stock repurchase programs, the entry into a Revolving Credit Agreement that replaces a previous credit facility, the announcement of quarterly financial results and the conditional definitive agreement to divest a majority ownership interest in the Pakistan affiliate Rafhan Maize while retaining a minority stake. Other 8-K items address the creation of direct financial obligations, termination of prior agreements and the timing of earnings releases and conference calls.
Investors reviewing Ingredion’s SEC filings can also find information on its capital structure, including revolving credit facilities, leverage and interest coverage covenants, and dividend and share repurchase activity as disclosed in earnings materials and current reports. Filings identify INGR as the trading symbol for Ingredion’s common stock on the New York Stock Exchange and confirm that the company is not classified as an emerging growth company. By using AI-powered tools to summarize and highlight key points from these documents, readers can more quickly understand Ingredion’s financial condition, segment performance, capital resources and significant corporate actions as reported in its SEC filings.
Ingredion reported mixed results for the quarter and year-to-date periods. Net sales were $1,833 million in Q2 2025 (down 2% year-over-year) and $3,646 million year-to-date (down 3%). Gross profit rose to $477 million in Q2 and $943 million year-to-date as raw material and input costs fell faster than sales, lifting gross margin to 26% year-to-date from 23% a year earlier. Operating income increased to $271 million in Q2 and $547 million year-to-date, a 21% year-over-year rise. Net income attributable to Ingredion was $196 million in Q2 and $393 million year-to-date; diluted EPS were $2.99 and $5.99, respectively.
Liquidity remained substantial with $861 million of cash and $3.7 billion of total available liquidity, while total debt stood at $1.8 billion with most maturities beyond 2026. Cash provided by operating activities declined to $262 million year-to-date from $521 million due to a $250 million working capital increase driven by higher accounts receivable. The company invested $19 million for a 49% stake in the Agrana joint venture, repurchased 409 thousand shares for $55 million year-to-date, and increased its quarterly dividend to $0.80 per share.
Ingredion Inc. (INGR) – Form 144 filing: Director/officer Larry Fernandes has filed notice of intent to sell 850 common shares through Fidelity Brokerage on or after 04 Aug 2025. At the stated aggregate market value of $109,131.50, the implied share price is roughly $128.39. The proposed sale represents less than 0.002% of the 64.3 million shares outstanding and therefore is immaterial to the company’s float.
The shares were acquired via restricted-stock vesting on 11 Feb 2025; no cash was paid because the grant was compensation. In the preceding three months Fernandes sold 360 shares for $49,330.80 (≈ $137.03 per share). No other sales are disclosed in the notice. By signing the form, the filer affirms no undisclosed material adverse information and acknowledges Rule 10b5-1 obligations.
While insider sales can occasionally foreshadow sentiment shifts, the low volume and routine nature of this transaction suggest minimal market impact. Investors may nevertheless monitor future filings for any acceleration in selling activity.
Ingredion Incorporated (INGR) filed a Form 4 showing that outside director Patricia Verduin received 290 shares of common stock on 30 June 2025. The shares, valued at $137.48 each, were issued under the company’s standard annual retainer program for non-employee directors and were coded “A” (acquisition) rather than an open-market purchase. After the grant, Verduin’s direct holdings rose to 2,751 shares. No derivative securities were involved, and no other insiders were listed on the filing. Because the award is routine board compensation and represents a market value of roughly $40,000—immaterial relative to Ingredion’s market capitalization—the transaction is unlikely to influence the company’s financial outlook or share price.